Top Markets
Coin of the day
SymBio Pharmaceuticals Limited SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals Limited

4582
Rangering i aksjer #28751
SymBio Pharmaceuticals Limited engages in the and development, manufacturing... SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.
Aksjekurs
$0.45018154
Markedsverdi
$24.81M
Endring (1 dag)
1.47%
Endring (1 år)
-56.57%
Land
JP
Handel SymBio Pharmaceuticals Limited (4582)

Kategori

EPS for SymBio Pharmaceuticals Limited (4582)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til SymBio Pharmaceuticals Limited er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for SymBio Pharmaceuticals Limited fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter